Ericure Remedies Private Limited

Ericure Remedies Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999MH2018PTC305057 Incorporated 13 February 2018 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.25 Cr
▼ 7% YoY
Net profit · FY 2025
₹28,384
Net margin 0.2%
EBITDA · FY 2025
₹1.59 Lakh
EBITDA margin 1.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Ericure Remedies Private Limited

Data last updated:

Ericure Remedies Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 February 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC305057. Its GSTIN is 27AAECE9317R1ZX (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajit Anil Mane and Vijay Dinkar Mohite.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.25 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹28,384 (net margin 0.2%) and EBITDA of ₹1.59 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999MH2018PTC305057
Registration Number 305057
Incorporation Date 13 February 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Ericure Remedies Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    A4 26A Narayan Plaza Off. Saki Vihar Road Chandivali Kurla Chandivali Near Kamani, Oil Mill, Mumbai, Maharashtra, India – 400058
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Ericure Remedies Private Limited, buy the company report.

Comprehensive company report
Ericure Remedies Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ericure Remedies is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Ericure Remedies Private Limited, buy the company report.

Financials of Ericure Remedies Private Limited

FY 2025 filings available

Ericure Remedies Private Limited reported revenue of ₹1.25 Cr (down 7% YoY) for FY 2025.

Revenue · FY 2025
₹1.25 Cr ▼ 7%
Net profit · FY 2025
₹28,384 margin 0.2%
EBITDA · FY 2025
₹1.59 Lakh margin 1.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 2%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 14%
3 years · compounded
▼ 11%
5 years · compounded
▼ 14%

Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.59 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹28,384
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.3%
Net Profit Margin0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ericure Remedies Private Limited, buy the company report.

Board of directors of Ericure Remedies Private Limited

Ericure Remedies has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ajit Anil ManeDirector13 Feb 20188 Years 8 MonthsCurrent
Vijay Dinkar MohiteDirector13 Feb 20188 Years 8 MonthsCurrent

Peer comparison

Ericure Remedies Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Standard Financial Consultants Private Limited₹1.25 Cr (FY 2025)3.0%Kolkata, West Bengal, India
Sanwadia Industries Private Limited₹1.25 Cr (FY 2025)-12.0%Jaipur, Rajasthan, India
Zoydec Pharmaceuticals Private Limited₹1.25 Cr (FY 2025)19.0%Chandigarh, India
Sany Cons Pvt Ltd₹1.25 Cr (FY 2025)-6.0%Kolkata, West Bengal, India
CLF Transtrade India Private Limited₹1.25 Cr (FY 2025)98.0%Ahmedabad, Gujarat, India
Ericure Remedies Private Limitedthis company₹1.25 Cr (FY 2025)₹28,3840.2%-7.0%Mumbai, Maharashtra, India
Abhinandan Creations Private Limited₹1.25 Cr (FY 2025)-18.0%New Delhi, Delhi, India
Dhanganga Distributors Private Limited₹1.25 Cr (FY 2024)-40.0%Kolkata, West Bengal, India
VKMG Enterprises Private Limited₹1.25 Cr (FY 2024)-27.0%New Delhi, Delhi, India
Healthtree Pharma (India) Private Limited₹1.25 Cr (FY 2025)-58.0%Chandigarh, India
Tuhin Chemicals Agency Pvt Ltd₹1.25 Cr (FY 2022)76.0%Kolkata, West Bengal, India

To see the full peer comparison of Ericure Remedies Private Limited, buy the company report.

Auditor

Ericure Remedies Private Limited is audited by ARVIND BANSAL & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
ARVIND BANSAL & COFY 2021100573W

Shareholding

The shareholding of Ericure Remedies Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Ericure Remedies Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ericure Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ericure Remedies has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECE9317R1ZXMaharashtraActive13 Apr 2018

To see the full GST registrations and return filing status of Ericure Remedies Private Limited, buy the company report.

Recent activity

Ericure Remedies Private Limited has 7 board changes on record since 2018: 2 appointments and 5 cessations. The latest: Amit Ashok Suryavanshi ceased to be Director on 03 Oct 2024.

AGM
Ericure Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ericure Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Amit Ashok Suryavanshi ceased to be Director.
Ceased
Rahul Kunhiraman Poduval ceased to be Additional Director.
Ceased
Radheshyam Suryanarayan Thakur ceased to be Director.
Ceased
Sachinam Sharma ceased to be Director.
Ceased
Rajesh Deviprasad Singh ceased to be Director.
Appointed
Ajit Anil Mane was appointed as Director.
Appointed
Vijay Dinkar Mohite was appointed as Director.
Incorporation
13 Feb 2018
Ericure Remedies Private Limited was registered on 13 Feb 2018 with Roc Mumbai I & aged 8 years 8 months as per MCA records.

Frequently asked questions

Ericure Remedies is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 February 2018 (8+ years old) and is registered under CIN U74999MH2018PTC305057.

Ericure Remedies has 2 current directors:

The latest financial statements of Ericure Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Ericure Remedies is 27AAECE9317R1ZX, registered in Maharashtra.

The CIN (Corporate Identification Number) of Ericure Remedies is U74999MH2018PTC305057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ericure Remedies was incorporated on 13 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Ericure Remedies by revenue are Standard Financial Consultants Private Limited, Sanwadia Industries Private Limited, Zoydec Pharmaceuticals Private Limited, Sany Cons Pvt Ltd, CLF Transtrade India Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Amit Ashok Suryavanshi ceased to be Director on 03 Oct 2024. Rahul Kunhiraman Poduval ceased to be Additional Director on 30 Nov 2021. Radheshyam Suryanarayan Thakur ceased to be Director on 10 Aug 2021. Ericure Remedies has 7 board changes on record in total.

The registered office of Ericure Remedies is at A4 26A Narayan Plaza Off. Saki Vihar Road Chandivali Kurla Chandivali Near Kamani, Oil Mill, Mumbai, Maharashtra, India – 400058.

Ericure Remedies operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Ericure Remedies is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.